Functional characterization of the rat mdr1b encoded P-glycoprotein: Not all inducing agents are substrates

Carcinogenesis

Volumn 18, Issue 11, 1997, Pages 2255-2263

  Santoni Rugiu, Eric ^a   Silverman, Jeffrey A ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b AvMax Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; COLCHICINE; CYTOTOXIC AGENT; DOXORUBICIN; FLUORENYLACETOHYDROXAMIC ACID; FLUOROURACIL; GLYCOPROTEIN P; VERAPAMIL; VINBLASTINE; XENOBIOTIC AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL STRAIN 3T3; CYTOTOXICITY; GENE EXPRESSION; MALE; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; RAT;

3T3 CELLS; AFLATOXIN B1; ANIMALS; HYDROXYACETYLAMINOFLUORENE; LIVER; MALE; MICE; P-GLYCOPROTEIN; RATS; RATS, INBRED F344; RHODAMINE 123; RHODAMINES; RNA, MESSENGER;

EID: 0031419012     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.11.2255     Document Type: Article

References (56)

1. Gottesman, M.M. and Pastan, I. (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem., 62, 385-427.
2. Borst, P., Schinkel, A.H., Smit, J.J.M., Wagenaar, E., van Deemter, L., Smith, A.J., Eijdems, W.H.M., Baas, F. and Zaman, G.J.R. (1993) Classical and novel forms of multidrug resistance and the physiological functions of P-glycoproteins in mammals. Pharmacol. Ther., 60, 289-299.
3. Endicott, J.A. and Ling, V. (1989) The biochemistry of P-glycoprotein mediated multidrug resistance. Annu. Rev. Biochem., 58, 137-171.
4. Goldstein, L.J. et al. (1989) Expression of a multidrug resistance gene in human cancers. J. Natl Cancer Inst., 81, 116-124.
5. Smit, J.J.M. et al. (1993) Homozygous disruption of the murine mdr2 p-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell, 75, 451-462.
6. Ruetz, S. and Gros, P. (1994) Phosphatidylcholine translocase: a physiological role for the mdr2 gene. Cell. 77, 1071-1081.
7. Smith, A.J., Timmermans-Hereijgers, J.L.P.M., Roelofsen, B., Wirtz, K.W.A., van Blitterswijk, W.J., Smit, J.J.M., Schinkel, A.H. and Borst, P. (1994) The human MDR3 P-glycoprotein promotes translocation of phosphotidylcholine through the plasma membrane of fibroblasts from transgenic mice. FEBS Lett., 354, 263-266.
8. van Helvoort, A., Smith, A.J., Sprong, H., Fritzsche, I., Schinkel, A.H., Borst, P. and van Meer, G. (1996) MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell. 87, 507-517.
9. Thiebaut, F., Tsuro, T. Hamada, H., Gottesman, M.M., Pastan, I. and Willingham, M.C. (1987) Cellular localization of the multidrug resistance gene product P-glycoprotein in normal human tissues. Proc. Natl Acad. Sci. USA, 84, 7735-7738.
10. Fojo, A.T., Ueda, K., Slamon, D.J., Poplack, D.G., Gottesman, M.M. and Pastan, I. (1987) Expression of a multidrug-resistance gene in human tumors and tissues. Proc. Natl Acad. Sci. USA, 84, 265-269.
11. Schinkel, A.H. et al. (1994) Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell, 77, 491-502.
12. Burt, R.K. and Thorgeirsson, S.S. (1988) Conduction of MDR-1 multidrug resistance and cytochrome P-450 genes in rat liver by xenobiotics. J. Natl Cancer Inst., 80, 1381-1386.
13. Gant, T.W., Silverman, J.A., Bisgaard, H.C. Burt, R.K., Marino, P.A. and Thorgeirsson, S.S. (1991) Regulation of 2-acetylaminofluorene and 3-methylcholanthrene mediated induction of mdr and cytochrome P450IA gene family expression in primary hepatocyte cultures and rat liver. Mol. Carcinogen., 4, 499-509.
14. Silverman, J.A. and Hill, B.A. (1995) Characterization of the basal and carcinogen regulatory elements of the rat mdr1b promoter. Mol. Carcinogen., 13, 50-59.
15. Hill, B.A., Brown, P.C., Preisegger, K.-H. and Silverman, J.A. (1996) Regulation of mdr1b gene expression in Fischer. Wistar and Sprague-Dawley rats in vivo and in vitro. Carcinogenesis, 17, 451-457.
16. Ueda, K., Cardarelli, C., Gottesman, M.M. and Pastan, I. (1987) Expression of a full length cDNA for the human 'MDR1' gene confers resistance to colchicine, doxorubicin and vinblastine. Proc. Natl Acad. Sci. USA, 84, 3004-3008.
17. Pastan, I., Gottesman, M.M., Ueda, K., Lovelace, E., Rutherford, A.V. and Willingham, M.C. (1988) A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. Proc. Natl Acad. Sci. USA, 85, 4486-4490.
18. Schurr, E., Raymond, M., Bell, J.C. and Gros, P. (1989) Characterization of the multidrug resistance protein expressed in cells stably transfected with the mouse md1l cDNA. Cancer Res., 49, 2729-2734.
19. Buschman, E. and Gros, P. (1991) Functional analysis of chimeric genes obtained by exchanging homologous domains of the mouse mdr1 and mdr2 genes. Mol. Cell. Biol. 11, 595-603.
20. Chirgwin, J.M., Przybyla, A.E., MacDonald, R.J. and Rutter, W.J. (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry, 18, 5294-5299 .
21. Legraverend, C., Mannah, R.R., Eisen, M.J., Owens, I.S., Nebert, D.W. and Hankinson, O. (1983) Regulatory gene product of the Ah locus. J. Biol. Chem., 257, 6402-6407.
22. Silvemian, J.A., Raunio, H., Gant, T.W. and Thorgeirsson, S.S. (1991) Cloning and characterization of a member of the rat multidrug resistance (mdr) gene family. Gene, 106, 229-236.
23. Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, 2nd Edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
24. Germann, U.A., Gottesman, M.M. and Pastan, I. (1989) Expression of a multidrug resistance-adenosine deaminase fusion gene. J. Biol. Chem., 264, 7418-7424.
25. Chieli, E., Santoni-Rugiu, E., Cervelli, F., Sabbatini, A., Petrini, M., Romiti, N., Paolicchi, A. and Tongiani, R. (1994) Differential modulation of P-glycoprotein expression by dexamethasone and 3-methylcholanthrene in rat hepatocyte primary cultures. Carcinogenesis, 15, 335-341.
26. Coon, J.S., Wang, Y., Bines, S.D., Markham, P.N., Chong, A.S.F. and Gebel, H.M. (1991) Multidrug resistance activity in human lymphocytes. Hum. Imnmnol., 32, 134-140.
27. Chieli, E., Santoni-Rugiu, E., Cervelli, F., Paolicchi, A. and Tongiani, R. (1993) Assessment of P-glycoprotein-dependent drug transport in isolated rat hepatocytes using rhodamine 123. Cell Biol. Toxicol., 9, 235-242.
28. Gant, T.W., Silverman, J.A. and Thorgeirsson, S.S. (1992) Regulation of P-glycoprotein gene expression in hepatocytes and liver cell lines by a transacting transcriptional repressor. Nucleic Acids Res., 20, 2841-2846.
29. Gant, T.W., Schrenk, D., Silverman, J.A. and Thorgeirsson, S.S. (1994) Requirement for metabolic activation of acetylaminofluorene to induce multidrug gene expression. Environ. Hlth Perspect., 102, 209-212.
30. Neyfakh, A. (1988) Use of fluorescent probes as molecular probes for the study of multidrug resistance. Exp. Cell. Res., 174, 168-176.
31. Kessel, D. (1989) Exploring multidrug resistance using rhodamine 123. Cancer Commun., 1, 145-149.
32. Ludescher, C., Thaler, J., Drach, D., Drach, J., Spitaler, M., Gattringer, C., Huber, H. and Hofmann, J. (1992) Detection of activity of P-glycoprotein in human tumour samples using rhodamine 123. Br. J. Haematol., 82, 161-168.
33. Devine, S.E. and Melera, P.W. (1994) Functional studies with a full-length P-glycoprotein cDNA encoded by the hamster pgpl gene. Cancer Chemother. Pharmacol., 33, 465-471.
34. Fairchild, C.R., Ivy, S.P. Rushmore, T., Lee, G., Koo, P. Goldsmith, M.E., Myers, C., Farber, E. and Cowan, K.H. (1987) Carcinogen-induced mdr overexpression is associated with xenobiotic resistance in rat preneoplastic liver nodules and hepatocellular carcinomas. Proc. Natl Acad. Sci. USA, 84, 7701-7705.
35. Thorgeirsson, S.S., Silverman, J.A., Gant, T.W. and Marino, P.A. (1991) Multidrug resistance gene family and chemical carcinogens. Pharmacol. Ther., 49, 283-292.
36. Schrenk, D., Gant, T.W., Michalke, A., Orzechowski, A., Silverman, J.A., Battula, N. and Thorgeirsson, S.S. (1994) Metabolic activation of 2-acetylaminofluorene is required for induction of multidrug resistance gene expression in rat liver cells. Carcinogenesis. 15, 2541-2546.
37. 1/2 mouse embryo fibroblasts on cell viability. Cancer Res., 40, 2904-2909.
38. 1/2 cells. Cancer Res., 43, 2659-2663.
39. Chin, K.-V., Chauhan, S.S., Pastan, I. and Gottesman, M.M. (1990) Regulation of mdr RNA levels in response to cytotoxic drugs in rodent cells. Cell Growth Differential., 1, 361-365.
40. Chin, K.-V., Tanaka, S., Darlington, G., Pastan, I. and Gottesman, M.M. (1990) Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells. J. Biol. Chem., 265, 221-226.
41. Miyazaki, M., Kohno, K., Uchiumi, T. Tanimura, H., Matsuo, K.-i., Nasu, M. and Kuwano, M. (1992) Activation of human multidrug resistance-1 gene promoter in response to heat shock stress. Biochem. Biophys. Res. Commun., 187, 677-684.
42. Uchiumi, T., Kohno, K., Tanimura, H., Hidaka, K., Asakuno, K., Abe, H., Uchida, Y. and Kuwano, M. (1993) Involvement of protein kinase in environmental stress-induced activation of human multidrug resistance 1 (MDR1) gene promoter. FEBS Lett., 326, 11-16.
43. Uchiumi, T., Kohno, K.,Tanimura, H., Matsuo, K.-i., Sato, S., Uchida, Y. and Kuwano, M. (1993) Enhanced expression of the human multidrug resistance 1 gene in response to UV light irradiation. Cell Growth Differential., 4, 147-157.
44. Kohno, K., Sato, S.-i., Takano, H., Matsuo, K.-i. and Kuwano, M. (1989) The direct activation of human multidrug resistance gene by anticancer agents. Biochem. Biophys. Res. Commun., 164, 1415-1421.
45. Kioka, N., Yamano, Y., Komano, T. and Ueda, K. (1992) Heat-shock responsive elements in the induction of the multidrug resistance gene (MDR1). FEBS Lett., 301, 37-40.
46. McCoy, C., Smith, D.E. and Cornwell, M.M. (1995) 12-O-Tetradecanoylphorbol-13-acetate activation of the MDR1 promoter is mediated by EGR1. Mol. Cell. Biol., 15, 6100-6108.
47. Yeh, G.C., Lopaczynska, J., Poore, C.M. and Phang, J.M. (1992) A new functional role for P-glycoprotein: efflux pump for benzo[a]pyrene in human breast cancer MCF-7 cells. Cancer Res., 52, 6692-6695.
48. Chaudhary, P.M. and Roninson, I.B. (1993) Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J. Natl Cancer Inst., 85, 632-639 .
49. Scarborough, G.A. (1995) Drug stimulated ATPase activity of the human P-glycoprotein. J. Bioenerg. Biomembr., 27, 37-41.
50. Baily, G.S. (1994) Role of aflatoxin DNA adducts in the cancer process. In Eaton, D.L. and Groopman, J.D. (eds) The Toxicology of Aflatoxins: Human Health, Veterinary and Agricultural Significance. Academic Press, New York, NY, pp. 137-148.
51. Kriek, E. (1992) Fifty years of research on N-acetyl-2-aminofluorene, one of the most versatile compounds in experimental cancer research. J. Cancer Res. Clin. Oncol., 118, 481-489.
52. Melchior, W.B. Jr, Marques, M.M. and Beland, F.A. (1994) Mutations induced by aromatic amine DNA adducts in pBR322. Carcinogenesis. 15, 889-899.
53. Paulusma, C.C., Bosma, P.J., Zaman, G.J.R., Bakker, C.T.M., Otter, M., Scheffer, G.L., Scheper, R.J., Borst, P. and Oude Elferink, R.P.J. (1996) Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science. 271, 1126-1128.
54. Cole, S.P.C. et al. (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science, 258, 1650-1654.
55. Schuetz, E.G., Beck, W.T. and Schuetz, J.D. (1996) Modulators and substrates of P-glycoprotein and cytochrome P450 3A coordinately up-regulate these proteins in human colon carcinoma cells. Mol. Pharmacol., 49, 311-318.
56. Wacher, V.J., Wu, C.-Y. and Benet, L.Z. (1995) Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancel-chemotherapy. Mol. Carcinogen., 13, 129-134.